COGT: Cogent Biosciences, Inc.
Performance
COGT +126.32%
Watchlist
Select an item
Summary
COGT at a glance
COGT returned +126.32% over the past year and +30.74% a year over five years. Its worst drop in that year was -34.43%, smaller than 48% of stocks on Redstone, and its Sharpe ratio of 1.02 beats 76% of stocks on Redstone. It pays no dividends.
Current Drawdown
-21.71%
Rolling Volatility
57.05%
Actions
Metrics
Risk Indicators
Alpha105.94%
Beta2.38x
Sharpe1.02
Sortino4.20
Omega1.48
Calmar3.67
Martin7.87
Profile
About COGT
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $5.8B
- Listed
- Mar 2018
- Employees
- 258
- Headquarters
- Waltham, MA
- Website
- cogentbio.com
Comparisons